Skip to main navigation Skip to search Skip to main content

Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor

  • Chun Ying Wu*
  • , Hsiu J. Ho
  • , Chen Yi Wu
  • , Yi Ju Chen
  • , Teng Yu Lee
  • , Yao Chun Hsu
  • , Jaw Town Lin
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)1598-1599
Number of pages2
JournalGut
Volume70
Issue number8
DOIs
StatePublished - 1 Aug 2021

Keywords

  • antibody targeted therapy
  • hepatoma
  • proton pump inhibition

Cite this